QC
IMUX icon

Quadrature Capital’s Immunic IMUX Stock Holding History

Quadrature Capital’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$581K Buy
37,786
+34,823
+1,175% +$430K 0.01% 965
2026
Q1 		$32.9K Buy
+2,963
New +$26.5K ﹤0.01% 1300
2025
Q2 		– Sell
-4,454
Closed -$48.1K – 1246
2025
Q1 		$48.1K Buy
+4,454
New +$48.1K ﹤0.01% 980

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Quadrature Capital's IMUX Position: Q2 2026 in Review

Quadrature Capital increased its Immunic (IMUX) stake by 1,175% in Q2 2026, buying an estimated $430K and bringing the position to 37,786 shares worth $581K. The position accounts for 0.01% of the portfolio, ranked #965.

Quadrature Capital first reported a position in IMUX in Q1 2025 and has held it in 3 quarters since. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Quadrature Capital held 37,786 shares of Immunic worth $581K as of Q2 2026.
  • Quadrature Capital bought 34,823 Immunic shares in Q2 2026, an estimated $430K.
  • Immunic made up 0.01% of Quadrature Capital's portfolio in Q2 2026, its #965 holding.
  • Quadrature Capital first reported a position in Immunic in Q1 2025 and has held it in 3 quarters since.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.